9.69
Niagen Bioscience Inc 주식(NAGE)의 최신 뉴스
Why is Niagen Bioscience Inc. stock attracting strong analyst attentionAdvanced Screener Report With Low Risk - jammulinksnews.com
Niagen Bioscience Inc. May Be Forming Higher Low — Chartwatchers AlertMarket Momentum Signal Generator Shows Trends - metal.it
What is the dividend policy of Niagen Bioscience Inc. stockExceptional gains - jammulinksnews.com
What is Niagen Bioscience Inc. company’s growth strategyAchieve rapid wealth accumulation through smart investing - jammulinksnews.com
Should I hold or sell Niagen Bioscience Inc. stock in 2025Invest confidently with professional guidance - jammulinksnews.com
How does Niagen Bioscience Inc. generate profit in a changing economyMaximize your investment portfolio’s performance - jammulinksnews.com
What makes Niagen Bioscience Inc. stock price move sharplyFree Investment Community - metal.it
Niagen Bioscience Inc. Stock Analysis and ForecastHigh-yield capital appreciation - PrintWeekIndia
What drives Niagen Bioscience Inc. stock priceFree Market Volatility Navigation Tips - PrintWeekIndia
Does Niagen Bioscience Inc. stock pay reliable dividendsTriple-digit return opportunities - jammulinksnews.com
Is Niagen Bioscience Inc. a good long term investmentOutstanding growth strategies - Autocar Professional
Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance
Niagen Bioscience to Report Second Quarter 2025 Financial Result - GuruFocus
Niagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - Business Wire
Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap dropped US$129m last week; individual investors who hold 33% were hit as were institutions - simplywall.st
What analysts say about Niagen Bioscience Inc. stockFree Consultation - Autocar Professional
Niagen Bioscience Shares Climb Following Exclusive License for Parkinson’s Therapy - MSN
Niagen Bioscience (NASDAQ:NAGE) Shares Down 4%Time to Sell? - MarketBeat
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Analysts Set Niagen Bioscience, Inc. (NASDAQ:NAGE) Target Price at $13.22 - Defense World
How Niagen Bioscience Inc. stock performs during market volatilityROI Driven Alerts - Newser
Why Niagen Bioscience Inc. stock attracts strong analyst attentionTop Growth Low Risk Stocks - Newser
자본화:
|
볼륨(24시간):